These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15672285)

  • 1. Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme.
    Martinez R; Schackert HK; Appelt H; Plaschke J; Baretton G; Schackert G
    J Cancer Res Clin Oncol; 2005 Feb; 131(2):87-93. PubMed ID: 15672285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation.
    Barresi V; Simbolo M; Mafficini A; Martini M; Calicchia M; Piredda ML; Ciaparrone C; Bonizzato G; Ammendola S; Caffo M; Pinna G; Sala F; Lawlor RT; Ghimenton C; Scarpa A
    Acta Neuropathol Commun; 2021 Dec; 9(1):200. PubMed ID: 34952640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel genetic alterations in samples of malignant glioma patients.
    Milinkovic V; Bankovic J; Rakic M; Stankovic T; Skender-Gazibara M; Ruzdijic S; Tanic N
    PLoS One; 2013; 8(12):e82108. PubMed ID: 24358143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability in pediatric and adult high-grade gliomas.
    Eckert A; Kloor M; Giersch A; Ahmadi R; Herold-Mende C; Hampl JA; Heppner FL; Zoubaa S; Holinski-Feder E; Pietsch T; Wiestler OD; von Knebel Doeberitz M; Roth W; Gebert J
    Brain Pathol; 2007 Apr; 17(2):146-50. PubMed ID: 17388945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite Instability in Glioblastoma: Is It Really Relevant in Tumor Prognosis?
    Tepeoglu M; Borcek P; Ozen O; Altinors N
    Turk Neurosurg; 2019; 29(5):778-784. PubMed ID: 31529454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.
    Cho YA; Kim D; Lee B; Shim JH; Suh YL
    J Neurooncol; 2021 May; 153(1):43-53. PubMed ID: 33864561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current State of Immunotherapy for Treatment of Glioblastoma.
    McGranahan T; Therkelsen KE; Ahmad S; Nagpal S
    Curr Treat Options Oncol; 2019 Feb; 20(3):24. PubMed ID: 30790064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different behaviour of DVL1, DVL2, DVL3 in astrocytoma malignancy grades and their association to TCF1 and LEF1 upregulation.
    Kafka A; Bačić M; Tomas D; Žarković K; Bukovac A; Njirić N; Mrak G; Krsnik Ž; Pećina-Šlaus N
    J Cell Mol Med; 2019 Jan; 23(1):641-655. PubMed ID: 30468298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification and characterization of microsatellite instability across 18 cancer types.
    Hause RJ; Pritchard CC; Shendure J; Salipante SJ
    Nat Med; 2016 Nov; 22(11):1342-1350. PubMed ID: 27694933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.
    Lee V; Murphy A; Le DT; Diaz LA
    Oncologist; 2016 Oct; 21(10):1200-1211. PubMed ID: 27412392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma multiforme therapy and mechanisms of resistance.
    Ramirez YP; Weatherbee JL; Wheelhouse RT; Ross AH
    Pharmaceuticals (Basel); 2013 Nov; 6(12):1475-506. PubMed ID: 24287492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of mismatch repair system in malignant astrocytomas.
    Rodríguez-Hernández I; Garcia JL; Santos-Briz A; Hernández-Laín A; González-Valero JM; Gómez-Moreta JA; Toldos-González O; Cruz JJ; Martin-Vallejo J; González-Sarmiento R
    PLoS One; 2013; 8(9):e76401. PubMed ID: 24073290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Changes in MGMT Promoter Methylation Status in Initial and Recurrent Glioblastomas.
    Park CK; Kim JE; Kim JY; Song SW; Kim JW; Choi SH; Kim TM; Lee SH; Kim IH; Park SH
    Transl Oncol; 2012 Oct; 5(5):393-7. PubMed ID: 23066447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic Events.
    Martínez R
    J Signal Transduct; 2012; 2012():519807. PubMed ID: 22778947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability in pediatric high grade glioma is associated with genomic profile and differential target gene inactivation.
    Viana-Pereira M; Lee A; Popov S; Bax DA; Al-Sarraj S; Bridges LR; Stávale JN; Hargrave D; Jones C; Reis RM
    PLoS One; 2011; 6(5):e20588. PubMed ID: 21637783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of microsatellite instability in medulloblastoma.
    Viana-Pereira M; Almeida I; Sousa S; Mahler-Araújo B; Seruca R; Pimentel J; Reis RM
    Neuro Oncol; 2009 Oct; 11(5):458-67. PubMed ID: 19179424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.
    Maxwell JA; Johnson SP; McLendon RE; Lister DW; Horne KS; Rasheed A; Quinn JA; Ali-Osman F; Friedman AH; Modrich PL; Bigner DD; Friedman HS
    Clin Cancer Res; 2008 Aug; 14(15):4859-68. PubMed ID: 18676759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some speculation on the origin of glioblastoma.
    Quigley MR; Post C; Ehrlich G
    Neurosurg Rev; 2007 Jan; 30(1):16-20; discussion 20-1. PubMed ID: 17123059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
    Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
    BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors.
    Srivastava T; Chosdol K; Chattopadhayay P; Sarkar C; Mahapatra AK; Sinha S
    J Neurooncol; 2007 Feb; 81(3):249-55. PubMed ID: 17019533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.